National Hepatology and Tropical Medicine Research Institute, Cairo

 The National Hepatology and Tropical Medicine Research Institute (NHTMRI) in Cairo is under the Ministry of Health and Population and performs research on hepatitis and tropical diseases. It hosts the Viral Hepatitis Research Laboratory (VHRL) which was established in 1998 to improve the infrastructure and research capabilities on hepatitis C in Egypt. It also has a Department of Tropical Medicine for in- and outpatients, with clinicians specialised in hepatology and tropical diseases. The laboratory is currently involved in both clinical and fundamental research studies related to different viral hepatitis infections in Egypt, and also performs routine testing for all chemical and blood investigations necessary for the patient management enrolled in the different studies.

image nhtmri 1

image nhtmri 2


The clinical team is headed by Prof. Gamal Esmat, a senior hepatologist from the University of Cairo. Gamal Esmat is currently the “South” coordinator of the ANRS research site in Egypt. He and his team have been involved in several clinical trials for the treatment of acute and chronic hepatitis C. Team: Drs Wafaa Elakel, Mohammed El Kassas, Mohammad Hassany, Aisha El Sharkawy, Mohammad El Sayed, and Abobakr Hasan.

Prof. Mohamed Abdel-Hamid MD PhD directs the VHRL and is affiliated to Minia University. He holds a faculty appointment at the University of Maryland in Baltimore. His team is composed of supervisors and technicians in addition to master degree and PhD thesis candidates. Dr. Ola Nada is associate Professor of Pathology in his team and is involved in the project.

Role in the collaboration

“South” coordination of ANRS research site. Virological research on HBV and HCV, with special expertise in the area of HCV molecular epidemiology and genotyping. Routine testing for HCV markers: viral load and serological diagnosis. Clinical research on HCV morbidity and treatment.


Back to team members



Introduction of Sofosbuvir in Egypt

In July 2014, Gilead and the Egyptian government signed an agreement for a treatment expansion of Sovaldi® (Sofosbuvir). Read more

Scientific Advisory Board Meeting

The Scientific Advisory Board Meeting was held in Paris February 15-16, 2013.

Read more

fp7_01fp7_02 This project is funded
by the European Union